Cite
MLA Citation
Koji Sasaki et al.. “Hyper‐CVAD plus ponatinib versus hyper‐CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A propensity score analysis.” Cancer, vol. 122, no. 23, 2016, pp. 3650–3656. http://access.bl.uk/ark:/81055/vdc_100039242094.0x000064